Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Opeyemi Olabisi
Associate Professor of Medicine
Medicine, Nephrology
opeyemi.olabisi@duke.edu
Research
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Appointments & Affiliations
Previous Appointments & Affiliations
Professional Training and Employment
expertise {hide_children: true, active: false, enabled: false}
Expertise
research {hide_children: false, active: true, enabled: true}
Research
Selected Grants
publications {hide_children: true, active: false, enabled: true}
Publications
Selected Publications
artistic-works {hide_children: true, active: false, enabled: false}
Artistic Works / Events
teaching {hide_children: true, active: false, enabled: false}
Teaching
advising-mentoring {hide_children: true, active: false, enabled: false}
Advising & Mentoring
recognition {hide_children: true, active: false, enabled: true}
Recognition
In the News
professional-activities {hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Selected Grants
Maze Therapeutics MZE829-201: An Open-Label Phase 2 Study to Evaluate the Safety, Tolerability, and Effect on Albuminuria of MZE829 in Adults with Proteinuric Chronic Kidney Disease and the APOL1 High Risk Genotype
Clinical Trial
Principal Investigator ·
Awarded by Maze Therapeutics ·
2025 - 2030
Endocrinology and Metabolism Training Program
Inst. Training Prgm or CME
Mentor ·
Awarded by National Institute of Diabetes and Digestive and Kidney Diseases ·
2024 - 2029
Identification of Host-Specific Determinants of APOL1-associated COVAN
Research
Mentor ·
Awarded by National Institute of Diabetes and Digestive and Kidney Diseases ·
2024 - 2029
Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education Program
Inst. Training Prgm or CME
Mentor ·
Awarded by National Institute of General Medical Sciences ·
2022 - 2027
Mechanisms of HIV persistence in the kidney (R01)
Research
Co-Principal Investigator ·
Awarded by National Institute of Diabetes and Digestive and Kidney Diseases ·
2022 - 2027
Medical Scientist Training Program
Inst. Training Prgm or CME
Preceptor ·
Awarded by National Institute of General Medical Sciences ·
2022 - 2027
REGULATORS OF CALCINEURIN PATHWAYS AS DIAGNOSTIC AND THERAPEUTIC TARGETS FOR NEPHROTIC SYNDROME
Research
Investigator ·
Awarded by National Institutes of Health ·
2023 - 2026
JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease
Research
Principal Investigator ·
Awarded by National Institute on Minority Health and Health Disparities ·
2021 - 2026
Etiology of Persistent Microalbuminuria in Nigeria
Research
Investigator ·
Awarded by Vanderbilt University Medical Center ·
2021 - 2026
A-018101 Lilly USA
Clinical Trial
Principal Investigator ·
Awarded by Lilly USA, LLC ·
2022 - 2026
NEPTUNE Public-Private Partnership ("MATCH Study")
Research
Principal Investigator ·
Awarded by Regents of the University of Michigan ·
2022 - 2025
Nephrotic Syndrome Rare Disease Clinical Research Network III (NEPTUNE III) ("Study")
Research
Co-Principal Investigator ·
Awarded by Regents of the University of Michigan ·
2019 - 2025
Alport Syndrome Natural History Ancillary Study
Research
Principal Investigator ·
Awarded by Regents of the University of Michigan ·
2023 - 2025
Nephcure
Research
Principal Investigator ·
Awarded by NEPHCURE Kidney International ·
2023 - 2024
Icagen SRA
Research
Principal Investigator ·
Awarded by Icagen, Inc ·
2021 - 2024
A Study of the Prevalence of Apolipoprotein L1 (APOL1) Alleles Among Individuals With Proteinuric Kidney Disease Who Are of Recent African Ancestry or Geographic Origin
Clinical Trial
Principal Investigator ·
Awarded by Vertex Pharmaceuticals Inc. ·
2020 - 2024
A Human Stem Cell-Derived Podocyte Model for APOL1 Nephropathy
Research
Principal Investigator ·
Awarded by National Institutes of Health ·
2019 - 2024
Duke Training Grant in Nephrology
Inst. Training Prgm or CME
Preceptor ·
Awarded by National Institutes of Health ·
1995 - 2023
A Phase 2a, Open-label, Single-arm, 2-Part Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VX¿147 in Adults With APOL1-dependent Focal Segmental Glomerulosclerosis
Clinical Trial
Principal Investigator ·
Awarded by Vertex Pharmaceuticals Inc. ·
2020 - 2022
A Natural History Study of Patients With Biopsy-proven Focal Segmental Glomerulosclerosis and Nephrotic Range Proteinuria Who Are of Recent African Ancestry or Have 2 APOL1 Risk Alleles
Clinical Trial
Principal Investigator ·
Awarded by Vertex Pharmaceuticals Inc. ·
2020 - 2022
Unmasking the Molecular Mechanism of ApoL1 Nephropathy
Research
Principal Investigator ·
Awarded by Robert Wood Johnson Foundation ·
2020 - 2020
